{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:04:29Z","timestamp":1773047069063,"version":"3.50.1"},"reference-count":32,"publisher":"Baishideng Publishing Group Inc.","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2015]]},"DOI":"10.3748\/wjg.v21.i21.6649","type":"journal-article","created":{"date-parts":[[2015,6,9]],"date-time":"2015-06-09T12:07:08Z","timestamp":1433851628000},"page":"6649","source":"Crossref","is-referenced-by-count":15,"title":["Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis"],"prefix":"10.3748","volume":"21","author":[{"given":"Le-Le","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2010.09.011"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00534-005-1009-9"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i41.15007"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresrev.2009.12.006"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7580.2011.01359.x"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-2824"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1089\/ten.TEA.2012.0649"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/jor.20694"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Stallcup WB, Huang FJ. A role for the NG2 proteoglycan in glioma progression. Cell Adh Migr 2008;2:192-201.","DOI":"10.4161\/cam.2.3.6279"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2008.01.007"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Mauvieux L, Delabesse E, Bourquelot P, Radford-Weiss I, Bennaceur A, Flandrin G, Valensi F, MacIntyre EA. NG2 expression in MLL rearranged acute myeloid leukaemia is restricted to monoblastic cases. Br J Haematol 1999;107:674-676.","DOI":"10.1046\/j.1365-2141.1999.01730.x"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2005.08.005"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2007.07.113"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjt010"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2012.09.008"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-014-9803-9"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetimm.2013.09.012"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.134"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-148X.2011.00929.x"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.0137-12.2012"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-013-9378-1"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2008.157"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2011.06.015"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2014.2399"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0000000000000084"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023062"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2013.07.065"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084883"},{"key":"ref29","unstructured":"Doane KJ, Howell SJ, Birk DE. Identification and functional characterization of two type VI collagen receptors, alpha 3 beta 1 integrin and NG2, during avian corneal stromal development. Invest Ophthalmol Vis Sci 1998;39:263-275."},{"key":"ref30","unstructured":"Iida J, Meijne AM, Spiro RC, Roos E, Furcht LT, McCarthy JB. Spreading and focal contact formation of human melanoma cells in response to the stimulation of both melanoma-associated proteoglycan (NG2) and alpha 4 beta 1 integrin. Cancer Res 1995;55:2177-2185."},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2004.11.021"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.2971"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v21\/i21\/6649.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T11:40:00Z","timestamp":1566819600000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v21\/i21\/6649.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":32,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v21.i21.6649","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}